Abstract | BACKGROUND: OBJECTIVES: We aimed at describing the current management. METHODS: RESULTS: The response rate to valid addresses was 25% (n=510/2006). In four scenarios, (a patient with mild disease undergoing a minor procedure; a patient with mild disease undergoing a more invasive procedure; a patient with severe disease undergoing a minor procedure; and a patient with severe disease undergoing a more invasive procedure) 80%, 38%, 27%, and 16% of respondents, respectively, would rely on oral fluids to hydrate patients during the preoperative fast, while 13%, 34%, 44%, and 59%, respectively, would use intravenous fluid. For the same four scenarios, 64%, 28%, 33%, and 10%, respectively, would not transfuse patients in an attempt to prevent sickle cell exacerbations, while 17%, 49%, 36%, and 51%, respectively, would transfuse to a hemoglobin concentration of 10 g·dl(-1). The tendencies to administer preoperative intravenous fluid and to transfuse blood increased with disease severity and procedure invasiveness (P<0.001). Although 89% felt comfortable managing patients with sickle cell disease, 73% thought an advisory statement on optimal perioperative management was needed. CONCLUSIONS: There is a wide variation in the management of children with sickle cell disease. Clinicians differentiate management based on disease severity and procedure type.
|
Authors | Paul G Firth, Kristen N McMillan, Charles M Haberkern, Myron Yaster, Michael A Bender, Salvatore R Goodwin |
Journal | Paediatric anaesthesia
(Paediatr Anaesth)
Vol. 21
Issue 1
Pg. 43-9
(Jan 2011)
ISSN: 1460-9592 [Electronic] France |
PMID | 20880153
(Publication Type: Journal Article)
|
Copyright | © 2010 Blackwell Publishing Ltd. |
Topics |
- Anemia, Sickle Cell
(therapy)
- Anesthesia
- Blood Transfusion
- Child
- Fluid Therapy
- Health Care Surveys
- Humans
- Intraoperative Care
- North America
- Perioperative Care
- Preoperative Care
- Referral and Consultation
|